Yokohama, Japan

Mayumi Kimura

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mayumi Kimura. Retrieved from https://idiyas.com/inventor/mayumi-kimura-aj5m7tmt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mayumi Kimura: Innovator in Pharmaceutical Chemistry

Introduction

Mayumi Kimura is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

One of her notable patents is titled "Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative." This invention provides a process for preparing a compound that is useful as an inhibitor of activated blood coagulation factor X. The compound has a complex structure that includes various functional groups, making it a valuable asset in the pharmaceutical industry.

Career Highlights

Mayumi Kimura is associated with Mitsubishi Tanabe Pharma Corporation, where she has been instrumental in advancing research and development efforts. Her work has led to innovative solutions in drug formulation and development.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Masahiko Seki and Shin-ichi Yoshida. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Mayumi Kimura's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the field. Her patent and collaborative efforts highlight her role as a key player in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…